Interestingly, autoantibodies targeting GAD65 are also valuable biomarkers for the diagnosis of type 1 diabetes mellitus (T1DM), as they are present in 80% of these patients, but generally at much lower levels [8]. Here, GAD2 is linked to type 1 diabetes mellitus.